MARISSA HUNTER: Open Payments
NPI 1043883036 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 35 payments from 12 companies in 2025. Trend: 2023 $859 · 2024 $931 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| Lilly USA, LLC | 9 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $79 |
| SHIELD THERAPEUTICS INC | 1 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Abbott Laboratories | 3 | $49 |
| Organon LLC | 3 | $43 |
| ABBVIE INC. | 2 | $40 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $17 |
Products named: AIRSUPRA, MOUNJARO, Kerendia, ACCRUFER, JARDIANCE, FREESTYLE LIBRE 3, NEXPLANON, ZENPEP.
Industry payments across OK — which companies pay providers there.
